CA-WARNER-BROS/DC
28.9.2016 16:34:31 CEST | Business Wire | Press release
Warner Bros. Consumer Products (WBCP) and DC Entertainment (DCE) today announced a partnership with the award-winning, pop powerhouse Fifth Harmony to collaborate on the first-ever DC Super Hero Girls music video, showcasing the pop sensation’s new single, “That’s My Girl.” Featuring Wonder Woman, Supergirl, Batgirl, Harley Quinn, Bumblebee, Poison Ivy and Katana, the animated DC Super Hero Girls music video is available for viewing on the official DC Super Hero Girls YouTube channel .
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160928005461/en/
“We all grew up with these strong female Super Heroes and it’s amazing to see how they have come together to show girls that anything is possible,” said the ladies of Fifth Harmony. “Our new single ‘That’s My Girl’ is the perfect anthem for DC Super Hero Girls and we are excited to team up with our new squad on this video to inspire young girls everywhere to feel powerful, strong and super.”
“That’s My Girl” is the newest single off Fifth Harmony’s recently released album 7/27 , named after the day the group first formed, which has received rave reviews from critics and fans alike. The video for “That’s My Girl” can be watched on the official DC Super Hero Girls YouTube channel and the song is available to download on all major music services.
“The members of Fifth Harmony are powerful role models for their millions of young fans and their anthem ‘That’s My Girl’ aligns perfectly with the DC Super Hero Girls mission to build character and promote confidence among young girls worldwide,” said Pam Lifford, President, Warner Bros. Consumer Products. “We are thrilled to collaborate with Fifth Harmony to celebrate our shared message of girl power.”
DC Super Hero Girls harnesses the power of the world’s most iconic female characters from DC, including Wonder Woman, Supergirl, and Batgirl, as they learn to hone their super powers in a high school setting. This all new universe offers young fans the chance to play, watch, read and be inspired to discover their full super power potential.
Join DC Super Hero Girls and Fifth Harmony to show your girl power on Instagram, Twitter and Facebook – #DCSuperHeroGirls #GetYourCapeOn.
The DC Super Hero Girls product assortment that includes everything from toys to costumes, apparel to accessories, publishing to stationery, and more is currently available at retailers and online around the world.
About DC Super Hero Girls
DC Super Hero Girls centers on the female Super Heroes and Super-Villains of the DC universe during their formative high school years—prior to discovering their full super power potential. Featuring a completely new artistic style and aesthetic, DC’s icons such as Wonder Woman, Supergirl, Batgirl, Harley Quinn, Bumblebee, Poison Ivy, Katana and many more, make their unprecedented teenaged introduction. Each character has her own storyline that explores what teen life is like as a Super Hero, including discovering her unique abilities, nurturing her remarkable powers and mastering the fundamentals of being a hero.
DC Super Hero Girls is a fun, immersive world that encourages girls to discover their own super-heroic potential with new animated shorts, TV specials, and made-for-video movies; as well as a merchandise program across all categories, and more. Random House Children’s Books continue to expand on its portfolio of middle-grade novels, with author Lisa Yee; and DC continues to create original graphic novels, with writer Shea Fontana – both publishing programs bringing the DC Super Hero Girls universe to life in all-new stories that expand the world from what is featured in the animated content. Fans can discover more at DCSuperHeroGirls.com and through dedicated social media platforms, including YouTube, Facebook and Instagram.
About Warner Bros. Consumer Products
Warner Bros. Consumer Products, a Warner Bros. Entertainment Company, is one of the leading licensing and retail merchandising organizations in the world.
About DC Entertainment
DC Entertainment, home to iconic brands DC (Superman, Batman, Green Lantern, Wonder Woman, The Flash, etc.), Vertigo (Sandman, Fables, etc.) and MAD, is the creative division charged with strategically integrating across Warner Bros. and Time Warner. DC Entertainment works in concert with many key Warner Bros. divisions to unleash its stories and characters across all media, including but not limited to film, television, consumer products, home entertainment, and interactive games. Publishing thousands of comic books, graphic novels and magazines each year, DC Entertainment is one of the largest English-language publishers of comics in the world.
Press materials are located at: wbcpmedia.warnerbros.com
DC SUPER HERO GIRLS and all related characters and elements © & ™ DC Comics. (s16)
View source version on businesswire.com: http://www.businesswire.com/news/home/20160928005461/en/
Contact:
Warner Bros. Consumer Products
Stephanie Clark
818.954.7308
stephanie.clark@warnerbros.com
or
B/HI
on behalf of WBCP
Molly Quiring
310.694.3021
molly_quiring@bhimpact.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom